All companies
Visit website
Pops
OperatingPOPS! Diabetes Care, Inc.
Healthcare · Technology · Founded 2015
Self-care AI med-tech platform and glucometer that enables people to manage their own diabetes.
Post-money valuation ⓘ
$17.9M
As of Jul 2022 · from POPS! Diabetes Care, Inc. Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$474,898
Across 3 rounds since 2021
Latest share price
$7.43
POPS! Diabetes Care, Inc. Preferred Stock 2 offering price
Financials
FY2019–FY2021 · from SEC filings · hover any figure for its source$6K
−$1.9M
2019
$29K
−$1.7M
2020
$163K
−$2.4M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
Income statement
Revenue
$5,994
$28,684
$163,164
Cost of goods sold
$12,105
$23,856
$446,239
Gross margin
-102%
17%
-173%
Net income
-$1,852,905
-$1,651,287
-$2,427,152
Taxes paid
$0
$0
$0
Balance sheet
Cash
$1,284,047
$1,426,581
$249,701
Accounts receivable
$0
$2,627
$28,080
Total assets
$2,167,607
$2,068,597
$1,166,946
Short-term debt
$424,040
$446,691
$792,560
Long-term debt
$188,400
$1,703,070
$2,880,394
Total liabilities
$612,440
$2,149,761
$3,672,954
Other
Headcount
—
8
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$25.0M
Valuation cap
$17.9M
post-money
Pops Convertible Note 1
POPS! Diabetes Care, Inc. Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $48.1K / $2.6MInvestors 41Post-money $17.9M
Raised $426.8K / $1.1MInvestors 41Valuation cap $25M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 5 annual reports (FY2021–FY2025)
41 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0001664262Share price $7.43
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.